Sun-Novo(SH:688621) Shang Hai Zheng Quan Bao·2025-11-21 18:49Core Viewpoint - The company is currently involved in a significant legal dispute with Hunan Hengsheng Pharmaceutical Co., Ltd, with the case now in the second instance of litigation, having been filed but not yet heard in court [2][5]. Summary by Sections Litigation Status - The case is in the second instance, which has been filed but not yet heard in court [2]. - The company is both the appellant and the appellee in this case, having been the defendant in the first instance and now filing a counterclaim [2]. Financial Implications - The amount involved in the original lawsuit is 20,000,000.00 yuan, while the counterclaim amounts to 7,407,283.51 yuan, and the first-instance judgment awarded 2,403,230.253 yuan [2]. - The company has fully provisioned for bad debts related to accounts receivable and contract assets from Hengsheng Pharmaceutical, indicating that the lawsuit will not negatively impact the company's current or future profits [2][7]. Legal Actions Taken - The company has filed an appeal against the first-instance judgment, seeking to overturn specific parts of the ruling and requesting that the court dismiss the plaintiff's claims while supporting the company's counterclaims [5]. - Hengsheng Pharmaceutical has also filed an appeal, requesting the enforcement of a technical development contract and seeking to amend the compensation awarded in the first-instance judgment [6][7].